Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 1/10

vs
industry
vs
history
Cash to Debt 0.29
HH's Cash to Debt is ranked higher than
51% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.29 vs. HH: 0.29 )
Ranked among companies with meaningful Cash to Debt only.
HH' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 65.70 Max: No Debt
Current: 0.29
Equity to Asset 0.17
HH's Equity to Asset is ranked lower than
84% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HH: 0.17 )
Ranked among companies with meaningful Equity to Asset only.
HH' s Equity to Asset Range Over the Past 10 Years
Min: 0.17  Med: 0.73 Max: 0.92
Current: 0.17
0.17
0.92
F-Score: 2
Z-Score: -10.62
M-Score: -0.98
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -25.70
HH's Operating margin (%) is ranked lower than
92% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. HH: -25.70 )
Ranked among companies with meaningful Operating margin (%) only.
HH' s Operating margin (%) Range Over the Past 10 Years
Min: -50.4  Med: -10.37 Max: 0.14
Current: -25.7
-50.4
0.14
Net-margin (%) -31.61
HH's Net-margin (%) is ranked lower than
94% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. HH: -31.61 )
Ranked among companies with meaningful Net-margin (%) only.
HH' s Net-margin (%) Range Over the Past 10 Years
Min: -46.65  Med: -29.71 Max: 0.89
Current: -31.61
-46.65
0.89
ROE (%) -189.13
HH's ROE (%) is ranked lower than
98% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. HH: -189.13 )
Ranked among companies with meaningful ROE (%) only.
HH' s ROE (%) Range Over the Past 10 Years
Min: -97.35  Med: -35.26 Max: 3.47
Current: -189.13
-97.35
3.47
ROA (%) -57.23
HH's ROA (%) is ranked lower than
97% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.42 vs. HH: -57.23 )
Ranked among companies with meaningful ROA (%) only.
HH' s ROA (%) Range Over the Past 10 Years
Min: -69.56  Med: -24.26 Max: 2.59
Current: -57.23
-69.56
2.59
ROC (Joel Greenblatt) (%) -257.74
HH's ROC (Joel Greenblatt) (%) is ranked lower than
94% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. HH: -257.74 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -387.36  Med: -46.49 Max: 6.95
Current: -257.74
-387.36
6.95
Revenue Growth (3Y)(%) -43.90
HH's Revenue Growth (3Y)(%) is ranked lower than
98% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. HH: -43.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.2  Med: -7.10 Max: 11.5
Current: -43.9
-47.2
11.5
EPS Growth (3Y)(%) 17.00
HH's EPS Growth (3Y)(%) is ranked higher than
66% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. HH: 17.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -9.20 Max: 64.8
Current: 17
0
64.8
» HH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

HH Guru Trades in Q1 2015

Jim Simons 849,800 sh (+1.38%)
» More
Q2 2015

HH Guru Trades in Q2 2015

Jim Simons 899,200 sh (+5.81%)
» More
Q3 2015

HH Guru Trades in Q3 2015

Jim Simons 1,029,400 sh (+14.48%)
» More
Q4 2015

HH Guru Trades in Q4 2015

Jim Simons 1,112,900 sh (+8.11%)
» More
» Details

Insider Trades

Latest Guru Trades with HH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 3.00
HH's P/B is ranked lower than
62% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 2.39 vs. HH: 3.00 )
Ranked among companies with meaningful P/B only.
HH' s P/B Range Over the Past 10 Years
Min: 0.31  Med: 1.50 Max: 11.4
Current: 3
0.31
11.4
P/S 0.31
HH's P/S is ranked higher than
87% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. HH: 0.31 )
Ranked among companies with meaningful P/S only.
HH' s P/S Range Over the Past 10 Years
Min: 0.06  Med: 0.39 Max: 2.03
Current: 0.31
0.06
2.03
Current Ratio 0.68
HH's Current Ratio is ranked lower than
79% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. HH: 0.68 )
Ranked among companies with meaningful Current Ratio only.
HH' s Current Ratio Range Over the Past 10 Years
Min: 0.68  Med: 2.41 Max: 9.6
Current: 0.68
0.68
9.6
Quick Ratio 0.63
HH's Quick Ratio is ranked lower than
80% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. HH: 0.63 )
Ranked among companies with meaningful Quick Ratio only.
HH' s Quick Ratio Range Over the Past 10 Years
Min: 0.63  Med: 2.37 Max: 9.6
Current: 0.63
0.63
9.6
Days Inventory 13.27
HH's Days Inventory is ranked higher than
58% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 16.67 vs. HH: 13.27 )
Ranked among companies with meaningful Days Inventory only.
HH' s Days Inventory Range Over the Past 10 Years
Min: 2.38  Med: 7.28 Max: 19.37
Current: 13.27
2.38
19.37
Days Sales Outstanding 94.04
HH's Days Sales Outstanding is ranked lower than
87% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 45.45 vs. HH: 94.04 )
Ranked among companies with meaningful Days Sales Outstanding only.
HH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.67  Med: 44.59 Max: 126.82
Current: 94.04
40.67
126.82
Days Payable 72.49
HH's Days Payable is ranked higher than
67% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 41.97 vs. HH: 72.49 )
Ranked among companies with meaningful Days Payable only.
HH' s Days Payable Range Over the Past 10 Years
Min: 14.15  Med: 19.63 Max: 70.67
Current: 72.49
14.15
70.67

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.80
HH's Price/Median PS Value is ranked higher than
70% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 0.96 vs. HH: 0.80 )
Ranked among companies with meaningful Price/Median PS Value only.
HH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.21  Med: 2.37 Max: 10.28
Current: 0.8
0.21
10.28
Price/Graham Number 0.38
HH's Price/Graham Number is ranked higher than
92% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. HH: 0.38 )
Ranked among companies with meaningful Price/Graham Number only.
HH' s Price/Graham Number Range Over the Past 10 Years
Min: 0.35  Med: 2.91 Max: 5.95
Current: 0.38
0.35
5.95
Earnings Yield (Greenblatt) (%) -51.50
HH's Earnings Yield (Greenblatt) (%) is ranked lower than
97% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 4.70 vs. HH: -51.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.8  Med: 5.90 Max: 8.3
Current: -51.5
2.8
8.3
Forward Rate of Return (Yacktman) (%) 249.89
HH's Forward Rate of Return (Yacktman) (%) is ranked higher than
99% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 11.02 vs. HH: 249.89 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HH' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -11.9  Med: -2.60 Max: 11.2
Current: 249.89
-11.9
11.2

More Statistics

Revenue(Mil) $29
EPS $ -0.12
Beta0.85
Short Percentage of Float0.80%
52-Week Range $0.05 - 0.63
Shares Outstanding(Mil)77.96

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, DVA, FSNUY, BDUUF, SKHCY » details
Hooper Holmes Inc was founded in 1899. The Company provides health risk assessment services. The Company along with its subsidiaries mobilizes a network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, insurance companies, employers, government organizations and academic institutions. The Company also conducts laboratory testing, assembles collection kits, conducts telephone interviews of life insurance applicants, compiles health histories, collects medical records and provides underwriting services to help life insurance companies evaluate underwriting risks. It is currently engaged in the following segments; Health and Wellness, Heritage Labs, Hooper Holmes Services. Health and Wellness, performs risk assessment and risk management services, including biometric screenings, health risk assessments and onsite wellness coaching for health and care management companies, including wellness companies, disease management organizations, clinical research organizations and, health plans as it manages the health services of corporate and government employees. Heritage Labs performs tests of blood, urine and oral fluid specimens, generated in connection with the paramedical exams and wellness screenings performed by third party paramedical service providers and its Health and Wellness segment, respectively, and assembles and sells specimen collection kits. The Hooper Holmes Services provides telephone interviews of insurance candidates, retrieval of medical records and inspections, risk management solutions and underwriting services for simplified issue products and products requiring full underwriting on behalf of insurance companies. All of the segments particularly health screenings and lab services of the Company are subject to federal and state regulation.
» More Articles for HH

Headlines

Articles On GuruFocus.com
Arquitos Capital Management Q1 2015 Investor Letter May 01 2015 
Hooper Holmes Inc Reports Operating Results (10-Q) Nov 05 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) Aug 06 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) May 07 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) Nov 06 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 50,000 Shares Aug 14 2009 
Hooper Holmes Inc Reports Operating Results (10-Q) Aug 07 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 25,326 Shares Jun 01 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 31,577 Shares May 29 2009 
Hooper Holmes Inc Reports Operating Results (10-Q) May 09 2009 

More From Other Websites
HOOPER HOLMES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing... Feb 10 2016
Hooper Holmes Provides Business Updates Feb 10 2016
HOOPER HOLMES INC Files SEC form 8-K, Other Events Jan 28 2016
HOOPER HOLMES INC Files SEC form 8-K, Other Events Jan 27 2016
Hooper Holmes Announces Successful Completion of Rights Offering Jan 27 2016
Hooper Holmes Announces Successful Completion of Rights Offering Jan 27 2016
Hooper Holmes Announces $12 Million Extension to Clinical Study Program Jan 15 2016
Hooper Holmes Announces $12 Million Extension to Clinical Study Program Jan 15 2016
Hooper Holmes Reschedules Close Date of Rights Offering Jan 04 2016
Hooper Holmes Reschedules Close Date of Rights Offering Jan 04 2016
Hooper Holmes Requests Effective Date for Rights Offering Dec 17 2015
Hooper Holmes Requests Effective Date for Rights Offering Dec 17 2015
HOOPER HOLMES INC Files SEC form 8-K/A, Financial Statements and Exhibits Dec 17 2015
HOOPER HOLMES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing... Dec 15 2015
Hooper Holmes Announces Terms of Rights Offering Dec 14 2015
Hooper Holmes Announces Terms of Rights Offering Dec 14 2015
Hooper Holmes, Inc. (HH): Hedge Funds Are Snapping Up Dec 10 2015
HOOPER HOLMES INC Financials Dec 08 2015
Hooper Holmes, Inc. Earnings Q3, 2015 Dec 01 2015
Hooper Holmes to Present at the LD Micro Main Event Nov 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK